The FDA has approved Zipsor (diclofenac potassium liquid filled capsules, from Xanodyne), a nonsteroidal antiinflammatory drug (NSAID), for the treatment of mild to moderate acute pain in adults ≥18 years old. This approval was based on the demonstration of safety and efficacy of Zipsor in two well controlled post-surgical bunionectomy clinical trials. Zipsor patients, at baseline, had an average pain intensity of 6.9 (on a 0 to 10 numeric pain rating scale).

For more information call (859) 371-6383 or visit www.xanodyne.com.